APA

Yamada Y., Naruse K., Nakamura K., Aoki S., Taki T., Tobiume M., Zennami K., Katsuda R., Hirano M., Hayashida K., Mizumukai E., Nanaura H. & Honda N. (20071213). Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization. : Oncology reports.

Chicago

Yamada Yoshiaki, Naruse Katsuya, Nakamura Kogenta, Aoki Shigeyuki, Taki Tomohiro, Tobiume Motoi, Zennami Kenji, Katsuda Remi, Hirano Miki, Hayashida Keiko, Mizumukai Emi, Nanaura Hiroshi and Honda Nobuaki. 20071213. Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization. : Oncology reports.

Harvard

Yamada Y., Naruse K., Nakamura K., Aoki S., Taki T., Tobiume M., Zennami K., Katsuda R., Hirano M., Hayashida K., Mizumukai E., Nanaura H. and Honda N. (20071213). Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization. : Oncology reports.

MLA

Yamada Yoshiaki, Naruse Katsuya, Nakamura Kogenta, Aoki Shigeyuki, Taki Tomohiro, Tobiume Motoi, Zennami Kenji, Katsuda Remi, Hirano Miki, Hayashida Keiko, Mizumukai Emi, Nanaura Hiroshi and Honda Nobuaki. Potential for molecular targeted therapy of HER-2/neu for invasive bladder cancer: examination of gene amplification by fluorescence in situ hybridization. : Oncology reports. 20071213.